Fluorescence-guided Surgery Using cRGD-ZW800-1 in Oral Cancer

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 12, 2022

Primary Completion Date

May 1, 2025

Study Completion Date

July 1, 2025

Conditions

Squamous Cell Carcinoma of the Head and NeckOral CancerSquamous Cell Carcinoma of the Oral Cavity

Interventions

DRUG

cRGD-ZW800-1.

Injection of cRGD-ZW800-1 within 48 hours before imaging/surgery

Trial Locations (1)

RECRUITING

Erasmus University Medical Center, Rotterdam